CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly earnings results, demand for Wegovy, drug pipeline outlook, Cagrisema ...

Global asset manager Rithm Capital Corp. RITM is set to report fourth-quarter 2024 results on Feb. 6, 2025, before the ...

T. Rowe Price Group noted improvements in earnings year over year, yet missed analysts' expectations for both EPS and revenue due to sizable net client outflows.

Bunge's agribusiness segment, which represents over 80% of its total revenue, saw adjusted core earnings decline to $364 ...

Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

The year for McDonald’s began as the brand hinted it would—with we hadn’t seen in nearly six calendars. The McValue platform, ...

Alphabet's Q4 results were far from inspiring, with the company’s revenue missing estimates and its key growth segment, ...